Correction: Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
Authors:
- Richard W. JosephRJRichard W. Joseph
- Jeroen Elassaiss-SchaapJEJeroen Elassaiss-Schaap
- Richard KeffordRKRichard Kefford
- Wen-Jen HwuWHWen-Jen Hwu
- Jedd D. WolchokJWJedd D. Wolchok
- Anthony M. JoshuaAJAnthony M. Joshua
- Antoni RibasARAntoni Ribas
- F. Stephen HodiFHF. Stephen Hodi
- Omid HamidOHOmid Hamid
- Caroline RobertCRCaroline Robert
- Adil DaudADAdil Daud
- Roxana DroncaRDRoxana Dronca
Open Access
- 1 December 2018
- journal article
- correction
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 24 (23) , 6098
Abstract
In the original version of [this article][1] ([1][2]), the stated disclosure of Jedd D. Wolchok is incorrect. The error has been corrected in the latest online HTML and PDF versions of the article. 1. 1.[↵][3]1. Joseph RW, 2. Elassaiss-Schaap J, 3. Kefford R, 4. Hwu WJ, 5Keywords
This publication has 1 reference indexed in Scilit: